These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 24657140)

  • 21. A novel bottom-up process to produce nanoparticles containing protein and peptide for suspension in hydrofluoroalkane propellants.
    Tan Y; Yang Z; Peng X; Xin F; Xu Y; Feng M; Zhao C; Hu H; Wu C
    Int J Pharm; 2011 Jul; 413(1-2):167-73. PubMed ID: 21527322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Understanding solvation in hydrofluoroalkanes: ab initio calculations and chemical force microscopy.
    Wu L; Peguin RP; da Rocha SR
    J Phys Chem B; 2007 Jul; 111(28):8096-104. PubMed ID: 17580855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aerosol generation by metered-dose inhalers containing dimethyl ether/propane inverse microemulsions.
    Sommerville ML; Hickey AJ
    AAPS PharmSciTech; 2003 Nov; 4(4):E58. PubMed ID: 15198553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improved intestinal delivery of salmon calcitonin by water-in-oil microemulsions.
    Fan Y; Li X; Zhou Y; Fan C; Wang X; Huang Y; Liu Y
    Int J Pharm; 2011 Sep; 416(1):323-30. PubMed ID: 21726618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Propellant-based inhalers for the non-invasive delivery of genes via oral inhalation.
    Conti DS; Bharatwaj B; Brewer D; da Rocha SR
    J Control Release; 2012 Feb; 157(3):406-17. PubMed ID: 21982899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Formulation, stability and pharmacokinetics of sugar-based salmon calcitonin-loaded nanoporous/nanoparticulate microparticles (NPMPs) for inhalation.
    Amaro MI; Tewes F; Gobbo O; Tajber L; Corrigan OI; Ehrhardt C; Healy AM
    Int J Pharm; 2015 Apr; 483(1-2):6-18. PubMed ID: 25660067
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The formulation of a pressurized metered dose inhaler containing theophylline for inhalation.
    Zhu B; Haghi M; Goud M; Young PM; Traini D
    Eur J Pharm Sci; 2015 Aug; 76():68-72. PubMed ID: 25956075
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The chlorofluorocarbon to hydrofluoroalkane transition: the effect on pressurized metered dose inhaler suspension stability.
    Brindley A
    J Allergy Clin Immunol; 1999 Dec; 104(6):S221-6. PubMed ID: 10588978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isothermal calorimetry: a predictive tool to model drug-propellant interactions in pressurized metered dose systems.
    Ooi J; Gaisford S; Boyd BJ; Young PM; Traini D
    Int J Pharm; 2014 Jan; 461(1-2):301-9. PubMed ID: 24325938
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Humidity affects the morphology of particles emitted from beclomethasone dipropionate pressurized metered dose inhalers.
    Ivey JW; Bhambri P; Church TK; Lewis DA; McDermott MT; Elbayomy S; Finlay WH; Vehring R
    Int J Pharm; 2017 Mar; 520(1-2):207-215. PubMed ID: 28167262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Encapsulation into PEG-liposomes does not improve the bioavailability of pulmonary delivered salmon calcitonin.
    Swaminathan J; Gobbo OL; Tewes F; Healy AM; Ehrhardt C
    J Aerosol Med Pulm Drug Deliv; 2014 Feb; 27(1):1-11. PubMed ID: 24252061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Review of Methods for Evaluating Particle Stability in Suspension Based Pressurized Metered Dose Inhalers.
    D'Sa D; Chan HK
    Curr Pharm Des; 2015; 21(27):3955-65. PubMed ID: 26290200
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of Aggregation-Caused Quenching Probe-Loaded Pressurized Metered-Dose Inhalers with Fluorescence Tracking Potentials.
    Wang W; Huang Z; Xue K; Li J; Wang W; Ma J; Ma C; Bai X; Huang Y; Pan X; Wu C
    AAPS PharmSciTech; 2020 Oct; 21(8):296. PubMed ID: 33099699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sub-micrometer particle production by pressurized metered dose inhalers.
    Crampton M; Kinnersley R; Ayres J
    J Aerosol Med; 2004; 17(1):33-42. PubMed ID: 15120011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The ester group: how hydrofluoroalkane-philic is it?
    Peguin RP; Wu L; da Rocha SR
    Langmuir; 2007 Jul; 23(16):8291-4. PubMed ID: 17602576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences in physical chemistry and dissolution rate of solid particle aerosols from solution pressurised inhalers.
    Buttini F; Miozzi M; Balducci AG; Royall PG; Brambilla G; Colombo P; Bettini R; Forbes B
    Int J Pharm; 2014 Apr; 465(1-2):42-51. PubMed ID: 24491530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Developing an in vitro understanding of patient experience with hydrofluoroalkane-metered dose inhalers.
    Doub WH; Shah V; Limb S; Guo C; Liu X; Ngo D
    J Pharm Sci; 2014 Nov; 103(11):3648-3656. PubMed ID: 25228114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nicotine microaerosol inhaler.
    Andrus PG; Rhem R; Rosenfeld J; Dolovich MB
    Can Respir J; 1999; 6(6):509-12. PubMed ID: 10623787
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Formulation of a protein with propellant HFA 134a for aerosol delivery.
    Williams RO; Liu J
    Eur J Pharm Sci; 1999 Jan; 7(2):137-44. PubMed ID: 9845798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of ethanol on the formation and physico-chemical properties of particles generated from budesonide solution-based pressurized metered-dose inhalers.
    Zhu B; Traini D; Chan HK; Young PM
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1625-37. PubMed ID: 24087854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.